Monte Rosa Therapeutics, Inc. (GLUE) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.35B and a free-cash-flow yield of -2.6%. Over the most recent reported fiscal year, revenue grew 63.5% and free cash flow per share fell 167.9%.